Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy.

MLA

Soulie, Cathia, et al. “Prevalence of Doravirine-Associated Resistance Mutations in HIV-1-Infected Antiretroviral-Experienced Patients from Two Large Databases in France and Italy.” Journal of Antimicrobial Chemotherapy (JAC), vol. 75, no. 4, Apr. 2020, pp. 1026–30. EBSCOhost, https://doi.org/10.1093/jac/dkz553.

APA

Soulie, C., Santoro, M. M., Storto, A., Abdi, B., Charpentier, C., Armenia, D., Jary, A., Forbici, F., Bertoli, A., Gennari, W., Andreoni, M., Mussini, C., Antinori, A., Perno, C. F., Calvez, V., Ceccherini-Silberstein, F., Descamps, D., & Marcelin, A.-G. (2020). Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy. Journal of Antimicrobial Chemotherapy (JAC), 75(4), 1026–1030. https://doi.org/10.1093/jac/dkz553

Chicago

Soulie, Cathia, Maria Mercedes Santoro, Alexandre Storto, Basma Abdi, Charlotte Charpentier, Daniele Armenia, Aude Jary, et al. 2020. “Prevalence of Doravirine-Associated Resistance Mutations in HIV-1-Infected Antiretroviral-Experienced Patients from Two Large Databases in France and Italy.” Journal of Antimicrobial Chemotherapy (JAC) 75 (4): 1026–30. doi:10.1093/jac/dkz553.